Antibodies

Antibodies

Primary Antibodies

B RAF

Human

Mouse

Rat

Dog

Monkey

Bovine

Human (Predicted: Mouse

Chicken

Primate

Sheep

Canine

Bovine)

Porcine

Cow)

Ferret

Hamster

Rabbit

Xenopus

Xenopus)

Rabbit)

Rat)

X. tropicalis)

Zebrafish

Chicken)

Cow

Drosophila

Equine

Fish

Goat

Guinea Pig

Hamster (Predicted: Bovine)

Human (Expected from sequence similarity: Mouse

Human (Predicted: Goat

Human (Predicted: Mouse)

Human (Predicted: Pig)

Human (Predicted: Xenopus

Insect

Mouse (Expected from sequence similarity: Rat

Mouse (Predicted: Chicken

Mouse (Predicted: Pig

Pig

Pig)

Rat (Expected from sequence similarity: Dog

Rhesus Monkey

FC

IF

IHC

WB

Rabbit

Unconjugated

Ig

Polyclonal

Druggable Genome

Protein Kinase

Pathways in cancer

Chronic myeloid leukemia

Focal adhesion

Progesterone-mediated oocyte maturation

Regulation of actin cytoskeleton

Acute myeloid leukemia

Arrhythmogenic right ventricular cardiomyopathy (ARVC)

Axon guidance

Biosynthesis of unsaturated fatty acids

Bladder cancer

Calcium signaling pathway

Cell cycle

Chemokine signaling pathway

Colorectal cancer

Dilated cardiomyopathy

Drug metabolism - cytochrome P450

ECM-receptor interaction

Endometrial cancer

ErbB signaling pathway

Fatty acid metabolism

Glioma

Glycolysis / Gluconeogenesis

Hematopoietic cell lineage

Huntington's disease

Hypertrophic cardiomyopathy (HCM)

Insulin signaling pathway

Limonene and pinene degradation

Long-term depression

Long-term potentiation

MAPK signaling pathway

Melanoma

Metabolic pathways

Metabolism of xenobiotics by cytochrome P450

Natural killer cell mediated cytotoxicity

Neuroactive ligand-receptor interaction

Neurotrophin signaling pathway

Non-small cell lung cancer

Notch signaling pathway

Pancreatic cancer

Prostate cancer

Purine metabolism

Regulation of autophagy

Renal cell carcinoma

Retinol metabolism

Small cell lung cancer

Thyroid cancer

Tyrosine metabolism

Ubiquitin mediated proteolysis

Vascular smooth muscle contraction

mTOR signaling pathway

2